首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   125篇
  免费   9篇
妇产科学   1篇
基础医学   25篇
口腔科学   2篇
临床医学   10篇
内科学   22篇
皮肤病学   1篇
神经病学   15篇
特种医学   1篇
外科学   39篇
预防医学   3篇
药学   11篇
中国医学   1篇
肿瘤学   3篇
  2022年   4篇
  2021年   10篇
  2020年   6篇
  2019年   12篇
  2018年   6篇
  2017年   7篇
  2016年   4篇
  2015年   6篇
  2014年   8篇
  2013年   7篇
  2012年   11篇
  2011年   13篇
  2010年   3篇
  2009年   4篇
  2008年   8篇
  2007年   12篇
  2006年   4篇
  2005年   2篇
  2004年   2篇
  1994年   1篇
  1987年   1篇
  1984年   1篇
  1978年   1篇
  1973年   1篇
排序方式: 共有134条查询结果,搜索用时 15 毫秒
131.
132.
Glycogen synthase kinase -3 (GSK-3) is a key enzyme involved in numerous physiological events and in major diseases, such as Alzheimer's disease, diabetes, and cardiac hypertrophy. Indirubins are bis-indoles that can be generated from various natural sources or chemically synthesized. While rather potent and selective as GSK-3 inhibitors, most indirubins exhibit low water solubility. To address the issue of solubility, we have designed novel analogues of 6-bromo-indirubin-3'-oxime with increased hydrophilicity based on the GSK-3/indirubins cocrystal structures. The new derivatives with an extended amino side chain attached at position 3' showed potent GSK-3 inhibitory activity, enhanced selectivity, and dramatically increased water solubility. Furthermore, some of them displayed little or no cytotoxicity. The new indirubins inhibit GSK-3 in a cellular reporter model. They alter the circadian period measured in rhythmically expressing cell cultures, suggesting that they might constitute tools to investigate circadian rhythm regulation.  相似文献   
133.
人工牛黄与几种新配方的药理学比较研究(Ⅱ)   总被引:4,自引:0,他引:4  
用比较药理学研究方法,对人工牛黄新配方E、F和G与现在药用人工牛黄的主要药效学在同等条件下进行了比较。结果表明,与现在药用人工牛黄一样,人工牛黄新配方E、F和G具有镇静、抗惊厥、解热、抗炎、增强非特异性免疫、护肝作用,作用强度与现在药用人工牛黄相近,或更强。  相似文献   
134.

Introduction

Multiple nodules in the lung are being diagnosed with an increasing frequency thanks to high-quality computed tomography imaging. In patients with lung cancer, this situation represents up to 10% of patients who have an operation. For clinical management, it is important to classify the disease as intrapulmonary metastasis or multiple primary lung carcinoma to define TNM classification and optimize therapeutic options. In the present study, we evaluated the respective and combined input of histological and molecular classification to propose a classification algorithm for multiple nodules.

Methods

We studied consecutive patients undergoing an operation with curative intent for lung adenocarcinoma (N = 120) and harboring two tumors (N = 240). Histological diagnosis according to the WHO 2015 classification and molecular profiling using next-generation sequencing targeting 22 hotspot genes allowed classification of samples as multiple primary lung adenocarcinomas or as intrapulmonary metastasis.

Results

Next-generation sequencing identified molecular mutations in 91% of tumor pairs (109 of 120). Genomic and histological classification showed a fair agreement when the κ test was used (κ = 0.43). Discordant cases (30 of 109 [27%]) were reclassified by using a combined histomolecular algorithm. EGFR mutations (p = 0.03) and node involvement (p = 0.03) were significantly associated with intrapulmonary metastasis, whereas KRAS mutations (p = 0.00005) were significantly associated with multiple primary lung adenocarcinomas. EGFR mutations (p = 0.02) and node involvement (p = 0.004) were the only independent prognostic factors.

Conclusion

We showed that combined histomolecular algorithm represents a relevant tool to classify multifocal lung cancers, which could guide adjuvant treatment decisions. Survival analysis underlined the good prognosis of EGFR-mutated adenocarcinoma in patients with intrapulmonary metastasis.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号